Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,680 public trials 156 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

NCT01119846

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Chula Vista, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Durham, North Carolina, United States
View Trial Details
Completed

Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes

NCT00659282

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Mississauga, Canada
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Vouliagment, Greece
  • Novo Nordisk Investigational Site Bangalore, India
View Trial Details
Completed

A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

NCT02754817

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Leipzig, Germany
  • Novo Nordisk Investigational Site Stockholm, Sweden
  • Novo Nordisk Investigational Site Sankt Gallen, Switzerland
View Trial Details
Completed

Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

NCT02210871

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +5 more
Locations
  • Novo Nordisk Investigational Site Warsaw, Poland
  • Novo Nordisk Investigational Site Wołomin, Poland
  • Novo Nordisk Investigational Site Bratislava, Slovakia
  • Novo Nordisk Investigational Site Bratislava, Slovakia
View Trial Details

Related conditions